Trial Profile
Predictors of cardioversion in patients with recent-onset atrial fibrillation treated with vernakalant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Vernakalant (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 09 Nov 2015 New trial record